相关实验视频

Updated: Jun 12, 2025

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

A Middle Cerebral Artery Occlusion Technique for Inducing Post-stroke Depression in Rats

Published on: May 22, 2019

治疗中风后情绪障碍的非药物干预:系统性审查

Vibha Balram^1,2, Rhianna Ingleton², Dave Parsons^2,3

¹College of Nursing and Health Sciences, Flinders University, Bedford Park, SA, Australia.

Topics in stroke rehabilitation

|September 18, 2024

概括

诸如体育炼和心理治疗等非药物干预措施显示出改善中风幸存者的抑郁和焦虑的前景. 需要进一步的研究,以探索它们对伪泡泡影响的影响.

科学领域:

神经康复疗法神经康复疗法
精神病学是一个精神病学.
基于证据的实践实践.

背景情况:

卒中幸存者经常经历抑郁,焦虑和伪泡泡状影响.
临床医生在鉴定有效的非药物干预措施方面面临挑战,因为证据不清楚.
缺乏对这些中风后疾病的非药物干预措施的系统审查.

研究的目的:

系统评估非药物干预治疗抑郁症,焦虑症和中风后个体的伪泡泡状影响的有效性.
综合来自随机对照试验的非药物治疗结果的证据.

主要方法:

按照PRISMA指南进行系统审查.
在 Medline,Scopus,CINAHL 和 PsycINFO 搜索了随机对照试验 (2012-2023).
包括研究评估非药物干预抑郁症,焦虑症和/或中风幸存者的伪泡泡状影响;数据以叙事方式合成.

主要成果:

包括42项研究,重点关注教育,心理治疗和体育炼.
心理治疗和体育炼证明了对抑郁症的积极结果.
运动和心理治疗对焦虑有效;机器人辅助治疗对抑郁症有希望.

结论:

非药物干预措施显示有可能改善中风幸存者的情绪.
机器人辅助治疗和体育炼似乎对多种结果有益.
患者教育应纳入幸存者和护理人员的康复.

关键词:

一次性中风,中风.情绪障碍情绪障碍情绪障碍非药物治疗的非药物治疗康复康复康复康复康复康复系统性审查系统性审查

更多相关视频

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits

Gathering Self-Initiated Rat Behavioral Data to Characterize Post-Stroke Deficits

Published on: March 15, 2024

A Human-machine-interface Integrating Low-cost Sensors with a Neuromuscular Electrical Stimulation System for Post-stroke Balance Rehabilitation

A Human-machine-interface Integrating Low-cost Sensors with a Neuromuscular Electrical Stimulation System for Post-stroke Balance Rehabilitation

Published on: April 12, 2016

相关概念视频

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...